Table of Content

1 Quadrivalent Meningococcal Vaccine Market Overview
1.1 Product Overview and Scope of Quadrivalent Meningococcal Vaccine
1.2 Quadrivalent Meningococcal Vaccine Segment by Type
1.2.1 Global Quadrivalent Meningococcal Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Polysaccharide Vaccine
1.2.3 Conjugate Vaccine
1.3 Quadrivalent Meningococcal Vaccine Segment by Application
1.3.1 Global Quadrivalent Meningococcal Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Quadrivalent Meningococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Quadrivalent Meningococcal Vaccine Revenue 2018-2034
1.4.2 Global Quadrivalent Meningococcal Vaccine Sales 2018-2034
1.4.3 Global Quadrivalent Meningococcal Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Quadrivalent Meningococcal Vaccine Market Competition by Manufacturers
2.1 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Quadrivalent Meningococcal Vaccine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Product Type & Application
2.7 Quadrivalent Meningococcal Vaccine Market Competitive Situation and Trends
2.7.1 Quadrivalent Meningococcal Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Quadrivalent Meningococcal Vaccine Players Market Share by Revenue
2.7.3 Global Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Quadrivalent Meningococcal Vaccine Retrospective Market Scenario by Region
3.1 Global Quadrivalent Meningococcal Vaccine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Quadrivalent Meningococcal Vaccine Global Quadrivalent Meningococcal Vaccine Sales by Region: 2018-2034
3.2.1 Global Quadrivalent Meningococcal Vaccine Sales by Region: 2018-2023
3.2.2 Global Quadrivalent Meningococcal Vaccine Sales by Region: 2024-2034
3.3 Global Quadrivalent Meningococcal Vaccine Global Quadrivalent Meningococcal Vaccine Revenue by Region: 2018-2034
3.3.1 Global Quadrivalent Meningococcal Vaccine Revenue by Region: 2018-2023
3.3.2 Global Quadrivalent Meningococcal Vaccine Revenue by Region: 2024-2034
3.4 North America Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country
3.4.1 North America Quadrivalent Meningococcal Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Quadrivalent Meningococcal Vaccine Sales by Country (2018-2034)
3.4.3 North America Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country
3.5.1 Europe Quadrivalent Meningococcal Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Quadrivalent Meningococcal Vaccine Sales by Country (2018-2034)
3.5.3 Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Quadrivalent Meningococcal Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Quadrivalent Meningococcal Vaccine Sales by Country (2018-2034)
3.7.3 Latin America Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Quadrivalent Meningococcal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Quadrivalent Meningococcal Vaccine Sales by Type (2018-2034)
4.1.1 Global Quadrivalent Meningococcal Vaccine Sales by Type (2018-2023)
4.1.2 Global Quadrivalent Meningococcal Vaccine Sales by Type (2024-2034)
4.1.3 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Quadrivalent Meningococcal Vaccine Revenue by Type (2018-2034)
4.2.1 Global Quadrivalent Meningococcal Vaccine Revenue by Type (2018-2023)
4.2.2 Global Quadrivalent Meningococcal Vaccine Revenue by Type (2024-2034)
4.2.3 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Quadrivalent Meningococcal Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Quadrivalent Meningococcal Vaccine Sales by Application (2018-2034)
5.1.1 Global Quadrivalent Meningococcal Vaccine Sales by Application (2018-2023)
5.1.2 Global Quadrivalent Meningococcal Vaccine Sales by Application (2024-2034)
5.1.3 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Quadrivalent Meningococcal Vaccine Revenue by Application (2018-2034)
5.2.1 Global Quadrivalent Meningococcal Vaccine Revenue by Application (2018-2023)
5.2.2 Global Quadrivalent Meningococcal Vaccine Revenue by Application (2024-2034)
5.2.3 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Quadrivalent Meningococcal Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Sanofi-Pasteur
6.1.1 Sanofi-Pasteur Corporation Information
6.1.2 Sanofi-Pasteur Description and Business Overview
6.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Portfolio
6.1.5 Sanofi-Pasteur Recent Developments/Updates
6.2 Walvax
6.2.1 Walvax Corporation Information
6.2.2 Walvax Description and Business Overview
6.2.3 Walvax Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Walvax Quadrivalent Meningococcal Vaccine Product Portfolio
6.2.5 Walvax Recent Developments/Updates
6.3 Chengdu Kanghua Biological Products Co., Ltd.
6.3.1 Chengdu Kanghua Biological Products Co., Ltd. Corporation Information
6.3.2 Chengdu Kanghua Biological Products Co., Ltd. Description and Business Overview
6.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio
6.3.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
6.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
6.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Corporation Information
6.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio
6.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
6.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Corporation Information
6.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio
6.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Beijing Institute of Biological Products Co., Ltd.
6.6.1 Beijing Institute of Biological Products Co., Ltd. Corporation Information
6.6.2 Beijing Institute of Biological Products Co., Ltd. Description and Business Overview
6.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio
6.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
6.7 CanSino Biological Co., Ltd.
6.6.1 CanSino Biological Co., Ltd. Corporation Information
6.6.2 CanSino Biological Co., Ltd. Description and Business Overview
6.6.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio
6.7.5 CanSino Biological Co., Ltd. Recent Developments/Updates
6.8 Hualan Biological Vaccine Co., Ltd.
6.8.1 Hualan Biological Vaccine Co., Ltd. Corporation Information
6.8.2 Hualan Biological Vaccine Co., Ltd. Description and Business Overview
6.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio
6.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
6.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
6.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Corporation Information
6.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Description and Business Overview
6.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolio
6.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Quadrivalent Meningococcal Vaccine Industry Chain Analysis
7.2 Quadrivalent Meningococcal Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Quadrivalent Meningococcal Vaccine Production Mode & Process
7.4 Quadrivalent Meningococcal Vaccine Sales and Marketing
7.4.1 Quadrivalent Meningococcal Vaccine Sales Channels
7.4.2 Quadrivalent Meningococcal Vaccine Distributors
7.5 Quadrivalent Meningococcal Vaccine Customers
8 Quadrivalent Meningococcal Vaccine Market Dynamics
8.1 Quadrivalent Meningococcal Vaccine Industry Trends
8.2 Quadrivalent Meningococcal Vaccine Market Drivers
8.3 Quadrivalent Meningococcal Vaccine Market Challenges
8.4 Quadrivalent Meningococcal Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Quadrivalent Meningococcal Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Quadrivalent Meningococcal Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Quadrivalent Meningococcal Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Quadrivalent Meningococcal Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Quadrivalent Meningococcal Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Quadrivalent Meningococcal Vaccine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Quadrivalent Meningococcal Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Quadrivalent Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Meningococcal Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Quadrivalent Meningococcal Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Quadrivalent Meningococcal Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Quadrivalent Meningococcal Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Quadrivalent Meningococcal Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Quadrivalent Meningococcal Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Quadrivalent Meningococcal Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Quadrivalent Meningococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Quadrivalent Meningococcal Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Quadrivalent Meningococcal Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Quadrivalent Meningococcal Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Quadrivalent Meningococcal Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Quadrivalent Meningococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Quadrivalent Meningococcal Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Quadrivalent Meningococcal Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Quadrivalent Meningococcal Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Quadrivalent Meningococcal Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Quadrivalent Meningococcal Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Quadrivalent Meningococcal Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. Sanofi-Pasteur Corporation Information
Table 71. Sanofi-Pasteur Description and Business Overview
Table 72. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product
Table 74. Sanofi-Pasteur Recent Developments/Updates
Table 75. Walvax Corporation Information
Table 76. Walvax Description and Business Overview
Table 77. Walvax Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Walvax Quadrivalent Meningococcal Vaccine Product
Table 79. Walvax Recent Developments/Updates
Table 80. Chengdu Kanghua Biological Products Co., Ltd. Corporation Information
Table 81. Chengdu Kanghua Biological Products Co., Ltd. Description and Business Overview
Table 82. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product
Table 84. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 85. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Corporation Information
Table 86. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Description and Business Overview
Table 87. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product
Table 89. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Corporation Information
Table 91. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Description and Business Overview
Table 92. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product
Table 94. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Beijing Institute of Biological Products Co., Ltd. Corporation Information
Table 96. Beijing Institute of Biological Products Co., Ltd. Description and Business Overview
Table 97. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product
Table 99. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 100. CanSino Biological Co., Ltd. Corporation Information
Table 101. CanSino Biological Co., Ltd. Description and Business Overview
Table 102. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product
Table 104. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 105. Hualan Biological Vaccine Co., Ltd. Corporation Information
Table 106. Hualan Biological Vaccine Co., Ltd. Description and Business Overview
Table 107. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product
Table 109. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 110. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Corporation Information
Table 111. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Description and Business Overview
Table 112. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product
Table 114. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Quadrivalent Meningococcal Vaccine Distributors List
Table 118. Quadrivalent Meningococcal Vaccine Customers List
Table 119. Quadrivalent Meningococcal Vaccine Market Trends
Table 120. Quadrivalent Meningococcal Vaccine Market Drivers
Table 121. Quadrivalent Meningococcal Vaccine Market Challenges
Table 122. Quadrivalent Meningococcal Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Quadrivalent Meningococcal Vaccine
Figure 2. Global Quadrivalent Meningococcal Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Quadrivalent Meningococcal Vaccine Market Share by Type in 2024 & 2034
Figure 4. Polysaccharide Vaccine Product Picture
Figure 5. Conjugate Vaccine Product Picture
Figure 6. Global Quadrivalent Meningococcal Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Quadrivalent Meningococcal Vaccine Market Share by Application in 2024 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Quadrivalent Meningococcal Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global Quadrivalent Meningococcal Vaccine Market Size (2018-2034) & (US$ Million)
Figure 12. Global Quadrivalent Meningococcal Vaccine Sales (2018-2034) & (K Units)
Figure 13. Global Quadrivalent Meningococcal Vaccine Average Price (US$/Unit) & (2018-2034)
Figure 14. Quadrivalent Meningococcal Vaccine Report Years Considered
Figure 15. Quadrivalent Meningococcal Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Quadrivalent Meningococcal Vaccine Players: Market Share by Revenue in 2024
Figure 18. Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global Quadrivalent Meningococcal Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2018-2034)
Figure 21. North America Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2018-2034)
Figure 22. United States Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2018-2034)
Figure 25. Europe Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2018-2034)
Figure 26. Germany Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2018-2034)
Figure 33. China Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. China Taiwan Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Southeast Asia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Latin America Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2018-2034)
Figure 41. Latin America Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2018-2034)
Figure 42. Mexico Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Brazil Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Argentina Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Colombia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2018-2034)
Figure 47. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2018-2034)
Figure 48. Turkey Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Saudi Arabia Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. UAE Quadrivalent Meningococcal Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Global Sales Market Share of Quadrivalent Meningococcal Vaccine by Type (2018-2034)
Figure 52. Global Revenue Market Share of Quadrivalent Meningococcal Vaccine by Type (2018-2034)
Figure 53. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Type (2018-2034)
Figure 54. Global Sales Market Share of Quadrivalent Meningococcal Vaccine by Application (2018-2034)
Figure 55. Global Revenue Market Share of Quadrivalent Meningococcal Vaccine by Application (2018-2034)
Figure 56. Global Quadrivalent Meningococcal Vaccine Price (US$/Unit) by Application (2018-2034)
Figure 57. Quadrivalent Meningococcal Vaccine Value Chain
Figure 58. Quadrivalent Meningococcal Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed